L&C Bio Co., Ltd (290650.KQ)

KRW 22450.0

(-1.54%)

Long Term Debt Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual long term debt in 2023 was 541.32 Million KRW , down -99.24% from previous year.
L&C Bio Co., Ltd's latest quarterly long term debt in 2024 Q2 was 458.04 Million KRW , down -8.33% from previous quarter.
L&C Bio Co., Ltd reported annual long term debt of 71.3 Billion KRW in 2022, up 1069.24% from previous year.
L&C Bio Co., Ltd reported annual long term debt of 6.09 Billion KRW in 2021, down -58.41% from previous year.
L&C Bio Co., Ltd reported quarterly long term debt of 499.68 Million KRW for 2024 Q1, down -7.69% from previous quarter.
L&C Bio Co., Ltd reported quarterly long term debt of 6.55 Billion KRW for 2023 Q2, down -89.25% from previous quarter.

Annual Long Term Debt Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Long Term Debt of L&C Bio Co., Ltd (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	541.32 Million KRW	-99.24%
2022	71.3 Billion KRW	1069.24%
2021	6.09 Billion KRW	-58.41%
2020	14.66 Billion KRW	803.79%
2019	1.62 Billion KRW	62.24%
2018	1 Billion KRW	0.0%
2017	- KRW	-100.0%
2016	401.3 Million KRW	-57.44%
2015	942.84 Million KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	458.04 Million KRW	-8.33%
2024 Q1	499.68 Million KRW	-7.69%
2023 Q2	6.55 Billion KRW	-89.25%
2023 Q4	541.32 Million KRW	-91.78%
2023 FY	541.32 Million KRW	-99.24%
2023 Q1	60.92 Billion KRW	-14.56%
2023 Q3	6.58 Billion KRW	0.46%
2022 FY	71.3 Billion KRW	1069.24%
2022 Q4	71.3 Billion KRW	13.72%
2022 Q3	62.7 Billion KRW	17.74%
2022 Q2	53.25 Billion KRW	868.43%
2022 Q1	5.49 Billion KRW	-9.82%
2021 Q1	14.15 Billion KRW	-3.48%
2021 Q4	6.09 Billion KRW	509.83%
2021 Q3	1 Billion KRW	0.0%
2021 Q2	1 Billion KRW	-92.93%
2021 FY	6.09 Billion KRW	-58.41%
2020 FY	14.66 Billion KRW	803.79%
2020 Q3	13.71 Billion KRW	1.58%
2020 Q4	14.66 Billion KRW	6.87%
2020 Q2	13.5 Billion KRW	-10.87%
2020 Q1	15.15 Billion KRW	834.03%
2019 Q3	1 Billion KRW	0.0%
2019 Q4	1.62 Billion KRW	62.24%
2019 FY	1.62 Billion KRW	62.24%
2019 Q2	1 Billion KRW	0.0%
2019 Q1	1 Billion KRW	0.0%
2018 Q2	1 Billion KRW	0.0%
2018 FY	1 Billion KRW	0.0%
2018 Q4	1 Billion KRW	0.0%
2017 Q4	- KRW	0.0%
2017 FY	- KRW	-100.0%
2016 FY	401.3 Million KRW	-57.44%
2015 FY	942.84 Million KRW	0.0%

Peer Long Term Debt Comparison of L&C Bio Co., Ltd

Name	Long Term Debt	Long Term Debt Difference
Osang Healthcare Co.,Ltd	367.49 Million KRW	-47.302%
InBody Co.,Ltd	3.63 Billion KRW	85.113%
Curexo Inc.	1.48 Billion KRW	63.624%
Seegene, Inc.	1.42 Billion KRW	61.971%
i-SENS, Inc.	45.74 Billion KRW	98.817%
Ray Co., Ltd.	155.4 Million KRW	-248.34%
Gencurix Inc.	5.47 Billion KRW	90.115%
Sugentech Inc.	240 Million KRW	-125.55%